Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model

Sridhar Reddy Chirasani, Oliver Grauer(University Hospital Münster), Katrin Stadler, Jochen Hochrein(University of Regensburg), Peter Hau(University Hospital Regensburg), Eva Gottfried(University of Regensburg), Petra Leukel, Ulrich Bogdahn(University Hospital Regensburg), Bernhard Neumann(University Hospital Regensburg), Wolfram Gronwald(University of Regensburg), Peter J. Oefner, Marina Kreutz(University of Regensburg)

International Journal of Cancer

July 3, 2012

10.1002/ijc.27712

Cited by 111

Related Papers

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

|The Lancet|2019|581

The Role of Selection in the Evolution of Human Mitochondrial Genomes

|Genetics|2005|464

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

|The Lancet|2017|401

Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice

|Nature Communications|2018|381

Srebp-controlled glucose metabolism is essential for NK cell functional responses

|Nature Immunology|2017|369